Man unsure of the safety of his medicine

Breaking news and expert analysis on legal and compliance issues

[Back To Home][Back To Archives]

From Products Liability Law Daily, November 20, 2014

OTC/prescription drug child-resistance packaging requirements enforcement stay extended

By Pamela C. Maloney, J.D.

The stay of enforcement of special packaging requirements for over-the-counter and prescription products containing the equivalent of 0.08 milligrams or more of a specified imidazoline (tetrahydrozoline, naphazoline, oxymetazoline, or xylometazoline) in a single package has been extended by the Consumer Product Safety Commission. The stay was set to expire on December 10, 2014. Firms that meet the conditions of the stay now have until June 10, 2015, to comply with the special packaging requirements. (CPSC Notice, 79 FR 69044, November 20, 2014).

Background. CPSC issued a rule (77 FR 73294, December 10, 2012) requiring special packaging (also called child-resistant or CR packaging) for any over-the-counter or prescription products containing the equivalent of 0.08 milligrams or more of a specified imidazoline in a single package (16 CFR 1700.14(a)(3)). The effective date of the rule was December 10, 2013; however, in consideration of concerns raised in comments on the proposed rule, the Commission gave imidazoline products manufacturers that are subject to the rule a 1-year conditional stay of enforcement.

Conditions of stay. In order to qualify for the stay, manufacturers of these products must: (a) provide notice to the Commission of intent to receive the benefit of the conditional stay of enforcement, which includes a detailed timeline setting forth the steps necessary for the firm to produce CR packaging for its products and a range of time anticipated for completion of each step; and (b) submit quarterly status reports during the 1-year stay of enforcement for each affected product. The reports must provide the following information: Proposed packaging specifications; estimated initial production date; progress made and/or steps completed during the quarterly reporting period; and reports of any incidents or exposures involving the firm's imidazoline-containing products subject to the rule.

Reasons for extension of stay. CPSC has granted the stay in response to notification by a number of firms that qualified for the stay that they would be unable to meet the CR packaging requirements before the expiration of the stay. The agency also concluded that the stay was justified based on a significant reduction in National Electronic Injury Surveillance System cases involving these products since the effective date of the final rule.

Firms could submit to CPSC a written request for additional time beyond the June 10, 2015, date. Such a request must specify the period of time needed to produce CR packaging, explain the reasons why additional time is needed and provide a timeline or schedule outlining what the firm will do to comply with the final rule.

MainStory: TopStory DrugsNews ChildrensProductsNews CPSCNews

Products Liability Law Daily

Introducing Wolters Kluwer Products Liability Law Daily — a daily reporting service created by attorneys, for attorneys — providing same-day coverage of breaking news, court decisions, legislation, and regulatory activity.


A complete daily report of the news that affects your world

  • View full summaries of federal and state court decisions.
  • Access full text of legislative and regulatory developments.
  • Customize your daily email by topic and/or jurisdiction.
  • Search archives for stories of interest.

Not just news — the right news

  • Get expert analysis written by subject matter specialists—created by attorneys for attorneys.
  • Track law firms and organizations in the headlines with our new “Who’s in the News” feature.
  • Promote your firm with our new reprint policy.

24/7 access for a 24/7 world

  • Forward information with special copyright permissions, encouraging collaboration between counsel and colleagues.
  • Save time with mobile apps for your BlackBerry, iPhone, iPad, Android, or Kindle.
  • Access all links from any mobile device without being prompted for user name and password.